Patent Law Weblog
recent posts
- Quo Vadis mRNA Vaccine Technology? The State of the IP Lawsuits
- Moderna Settles Patent Litigation with Arbutus et al.
- USPTO and DOJ Statement of Interest in Collision Communications: Another Thumb on the Scale in Favor of NPE Patent Plaintiffs
- Oasis Tooling, Inc. v. Siemens Industry Software Inc. (Fed. Cir. 2026)
- Why AI Will Not Take Over the World
about
Category: Biotech/Pharma Business
-
By Jason Derry — Genentech and AC Immune have announced a $300 million licensing agreement relating to the development of antibodies for treating Alzheimer's disease. AC Immune's research in the Alzheimer's area includes inducing anti-beta amyloid antibody production in patients. The announcement marks the third recent major licensing deal between Genentech and a…
-
By Jason Derry — Targeted Genetics Corp. has announced a non-exclusive licensing deal with Amsterdam Molecular Therapeutics B.V. relating to the use of the AAV1 (Adeno-Associated Virus Type 1) vector. The licensed AAV1 vector is covered by U.S. Patent Nos. 6,759,237 and 7,105,345. AMT intends to use the vector for developing therapeutics for…
-
By Jason Derry — The Milken Institute, an independent think tank, has released a report that proposes a strategy that may stimulate increased funding efforts for early-stage biotech research. The strategy essentially involves public-private partnerships. The need to stimulate funding efforts for biomedical research stems from decreased or stagnant public funding, and from…
-
By Christopher P. Singer — I am always impressed by the variety of investment vehicles and innovative methods that investors and businesses use to generate money. Back on October 25, 2006, Ocean Tomo, an intellectual capital merchant banc that specializes in a variety of services related to intellectual property, announced the launch of…
-
By Jason Derry — Merck & Co., Inc. has begun the process of moving a compound discovered in an effort with partner Isis Pharmaceuticals, Inc. toward clinical trials. The compound was discovered as part of a collaborative agreement between Merck and Isis, in which Merck relied on Isis' familiarity with technology relating to nucleic…
-
By Jason Derry — Affymetrix Inc. and Baylor College of Medicine have entered into an agreement in which Baylor receives a non-exclusive, worldwide license to use Affymetrix's comparative genomic hybridization (CGH) microarrays. Baylor intends to use the microarrays in services provided in Clinical Laboratory Improvement Amendments (CLIA) environments. The Press Release providing this news…
-
By Jason Derry — As reported by the San Diego Union Tribune, the Scripps Research Institute and Pfizer Inc. have agreed on a 5 year, $100 million partnership. The arrangement provides Pfizer the option of licensing up to 47% of the discoveries made at Scripps over the next 5 years, while Scripps receives…
-
By Jason Derry — North Carolina based INC Research® has announced that Dr. Tetsushi Inada will be its senior liaison officer to Japan. The appointment is part of INC Research’s initiative to expand its clinical expertise services and increase its presence in Asian countries. INC Research® is a contract research organization that specializes…
-
By Jason Derry — Dyax Corp. and the Australian national scientific research agency, CSIRO, have announced a collaborative partnership to discover and develop antibodies for treating cancer. Dyax will provide the antibody libraries and screen for potential clinical leads, while CSIRO will test the leads and work on developing the leads into clinically…
-
By Jason Derry — The Philadelphia Inquirer reported today that Delaware has instituted a new agency to receive donated patents with the goal of inspiring economic growth within the State. The agency hopes to generate Delaware-based companies through licensing of its available patents. The agency currently has over 250 patents from DuPont Co.…
Patent Docs 